"We are pleased to expand commercial access to QUELIMMUNE and are extremely proud to be the only company to develop and commercialize a therapeutic device that has demonstrated clinical results to ...

Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty ...

Mr. Ainsworth brings over two decades of industry and market access experience to Tonix U.S. Food and Drug Administration (FDA) recently assigned a Prescription Drug User Fee Act (PDUFA) goal date of ...

Raises 2025 Financial Guidance Ranges for Total Revenue to $1,150 - $1,225 million, Representing YoY Growth of 16% - 23%, Adjusted EBITDA of $755 - $805 million, Representing YoY Growth of 24% - 32%, ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

Legend Biotech is a commercial-stage biotech company specializing in innovative cell therapies. Click here to find out why I ...

The U.S. Food and Drug Association (FDA) released the first-ever guidelines for levels of lead in processed baby foods ...

For the second year in a row, 2024 was a banner year for the regulation of per- and polyfluoroalkyl substances (PFAS) at the federal level.

CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.

Dual-listed regenerative medicine company Avita Medical has seen its share price slide ~19% today on a downgrade of its ...

With multiple stakeholders involved with different interests, the “specialty drug” definition can be a moving target.